Manufacturing Establishments1
FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.
Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC
840771732
Products2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Deferoxamine
Product Details
NDC Product Code
63323-597Application Number
ANDA078718Marketing Category
ANDA (C73584)Route of Administration
INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUSEffective Date
May 16, 2017DeferoxamineActive
Code: V9TKO7EO6KClass: ACTIBQuantity: 95 mg in 1 mL
Deferoxamine
Product Details
NDC Product Code
63323-599Application Number
ANDA078718Marketing Category
ANDA (C73584)Route of Administration
INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUSEffective Date
May 16, 2017DeferoxamineActive
Code: V9TKO7EO6KClass: ACTIBQuantity: 95 mg in 1 mL